摘要:
The present invention lies in the field of the treatment and prophylaxis of infectious diseases. It relates to the prophylaxis and treatment of bacterial infections of the respiratory tract caused by gram-positive bacteria or other susceptible bacterial pathogens in a patient, comprising the lantibiotic Gallidermin or a pharmaceutically active variant thereof as active substance, and related subject matters.
摘要:
The invention relates to a pharmaceutical composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor. In addition a method of treating cyclooxygenase dependent disorders, including inflammation, pain and/or rheumatic diseases, and/or neoplasia is described.
摘要:
The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
摘要:
The present invention lies in the field of the treatment and prophylaxis of infectious diseases. It relates to the prophylaxis and treatment of bacterial infections of the respiratory tract caused by gram-positive bacteria or other susceptible bacterial pathogens in a patient, comprising the lantibiotic Gallidermin or a pharmaceutically active variant thereof as active substance, and related subject matters.
摘要:
The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
摘要:
The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
摘要:
The present invention relates to a method for prevention of the transmission of a pathogen of an animal of a first species to an animal of a second species characterized in that antigen of the pathogen of the animal of the first species is used for the immunization of the animal of the second species against the pathogen of the animal of the first species, wherein the administration of said antigen results in the reduction or the absence of the reproduction of pathogen of the animal of the first species in the animal of the second species.
摘要:
The invention relates to a novel use of bradycardiac substances such as a Ca channel blocker, beta-receptor blockers or if channel blockers, the if channel blockers being preferred. Said substances are optionally used in combination with a cardio-active substance for inducing the regression of myocardial diseases associated with hypertrophy, in particular for treating ideopathic hypertrophic cardiomyopathies (HCM) in humans and domestic animals.
摘要:
The present invention relates to a phosphodiesterase type III (PDE III) inhibitor and/or Ca 2+ - sensitizing agent or a pharmaceutically acceptable derivative thereof for the treatment of a patient suffering from hypertrophic cardiomyopathy (HCM). According to another aspect the present invention relates to the use of a PDE III inhibitor and/or Ca 2+ -sensitizing agent for the preparation of a medicament for the treatment of a patient suffering from HCM.
摘要:
The present invention provides a method for improving diagnostic quality in echocardiography, especially for patients having an elevated heart rate.